Aquatic Capital Management’s GSK GSK Stock Holding History

Aquatic Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.26M	Buy	43,060 +36,998	+610%	+$1.96M	0.08%	333
2026 Q1	$335K	Sell	6,062 -351,755	-98%	-$19.1M	0.01%	868
2025 Q4	$17.5M	Buy	357,817 +189,342	+112%	+$8.83M	0.5%	46
2025 Q3	$7.27M	Sell	168,475 -261,990	-61%	-$10.2M	0.13%	188
2025 Q2	$16.5M	Buy	430,465 +97,764	+29%	+$3.74M	0.33%	79
2025 Q1	$12.9M	Sell	332,701 -91,095	-21%	-$3.33M	0.33%	71
2024 Q4	$14.3M	Buy	423,796 +258,096	+156%	+$9.29M	0.39%	63
2024 Q3	$6.77M	Buy	165,700 +57,800	+54%	+$2.36M	0.18%	146
2024 Q2	$4.15M	Buy	107,900 +49,000	+83%	+$2.06M	0.15%	139
2024 Q1	$2.53M	Sell	58,900 -18,100	-24%	-$746K	0.08%	224
2023 Q4	$2.85M	Sell	77,000 -2,700	-3%	-$96.9K	0.07%	255
2023 Q3	$2.89M	Buy	79,700 +6,900	+9%	+$245K	0.12%	181
2023 Q2	$2.6M	Buy	+72,800	New	+$2.61M	0.14%	161
2022 Q4	–	Sell	-30,200	Closed	-$889K	–	1547
2022 Q3	$889K	Buy	30,200 +21,800	+260%	+$826K	0.09%	293
2022 Q2	$457K	Buy	8,400 +7,840	+1,400%	+$433K	0.15%	173
2022 Q1	$30K	Buy	+560	New	+$30.4K	0.04%	390

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Aquatic Capital Management's GSK Position: Q2 2026 in Review

Aquatic Capital Management increased its GSK (GSK) stake by 610% in Q2 2026, buying an estimated $1.96M and bringing the position to 43,060 shares worth $2.26M. The position accounts for 0.08% of the portfolio, ranked #333.

Aquatic Capital Management first reported a position in GSK in Q1 2022 and has held it in 16 quarters since. The position peaked at $17.5M in Q4 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Aquatic Capital Management held 43,060 shares of GSK worth $2.26M as of Q2 2026.
Aquatic Capital Management bought 36,998 GSK shares in Q2 2026, an estimated $1.96M.
GSK made up 0.08% of Aquatic Capital Management's portfolio in Q2 2026, its #333 holding.
Aquatic Capital Management first reported a position in GSK in Q1 2022 and has held it in 16 quarters since.
Aquatic Capital Management's GSK position peaked at $17.5M in Q4 2025.
1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.